Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Federal Trade Commission
Cipla
Baxter
McKesson
US Army
Covington
Chubb
Express Scripts

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021330

« Back to Dashboard

NDA 021330 describes COMMIT, which is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from three suppliers. Additional details are available on the COMMIT profile page.

The generic ingredient in COMMIT is nicotine polacrilex. There are twenty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.
Summary for 021330
Tradename:COMMIT
Applicant:Glaxosmithkline Cons
Ingredient:nicotine polacrilex
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021330
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
COMMIT nicotine polacrilex TROCHE/LOZENGE;ORAL 021330 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0510 N 0135-0510-06
COMMIT nicotine polacrilex TROCHE/LOZENGE;ORAL 021330 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0135-0510 N 0135-0510-03

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TROCHE/LOZENGE;ORALStrengthEQ 2MG BASE
Approval Date:Oct 31, 2002TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:OTCDosage:TROCHE/LOZENGE;ORALStrengthEQ 4MG BASE
Approval Date:Oct 31, 2002TE:RLD:Yes

Expired US Patents for NDA 021330

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons COMMIT nicotine polacrilex TROCHE/LOZENGE;ORAL 021330-001 Oct 31, 2002 ➤ Sign Up ➤ Sign Up
Glaxosmithkline Cons COMMIT nicotine polacrilex TROCHE/LOZENGE;ORAL 021330-002 Oct 31, 2002 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Mallinckrodt
Johnson and Johnson
Fish and Richardson
Cipla
Fuji
QuintilesIMS
Argus Health
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot